Aushon Partners with LightArray to Serve Pharma Clients and Increase Access to Chinese Market

A LightArray official said that demand for biomarker services is on the rise in China. "As the population of China is very large, the requirements for clinical diagnostics are [also] very large."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.